Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 393.50 | 423.61 | 433.65 | 300.36 |
Total Revenue | 393.50 | 423.61 | 433.65 | 300.36 |
Costof Revenue Total | 174.18 | 258.20 | 230.30 | 168.28 |
Gross Profit | 219.32 | 165.41 | 203.35 | 132.08 |
Selling/ General/ Admin Expenses Total | 54.76 | 97.39 | 94.83 | 65.57 |
Depreciation/ Amortization | 25.61 | 9.56 | 8.18 | 6.73 |
Other Operating Expenses Total | 96.37 | 0.13 | 0.16 | 0.00 |
Total Operating Expense | 350.91 | 365.28 | 333.46 | 240.59 |
Operating Income | 42.59 | 58.34 | 100.19 | 59.77 |
Interest Inc( Exp) Net- Non- Op Total | -65.32 | -114.01 | 44.54 | 1.03 |
Gain( Loss)on Saleof Assets | 0.00 | -35.88 | -0.51 | -0.34 |
Other Net | 7.51 | 1.43 | -0.47 | 0.86 |
Net Income Before Taxes | 43.57 | 44.78 | 104.12 | 60.70 |
Provisionfor Income Taxes | 13.21 | -0.71 | 8.25 | 8.43 |
Net Income After Taxes | 30.35 | 45.49 | 95.87 | 52.26 |
Net Income Before Extra Items | 30.35 | 45.49 | 95.87 | 52.26 |
Net Income | 30.35 | 45.49 | 95.87 | 52.26 |
Income Availableto Com Excl Extra Ord | 30.35 | 45.49 | 95.87 | 52.26 |
Income Availableto Com Incl Extra Ord | 30.35 | 45.49 | 95.87 | 52.26 |
Diluted Net Income | 30.35 | 45.49 | 95.87 | 52.26 |
Diluted Weighted Average Shares | 2.29 | 2.22 | 2.15 | 2.22 |
Diluted EPS Excluding Extra Ord Items | 13.26 | 20.52 | 44.59 | 23.58 |
DPS- Common Stock Primary Issue | 2.00 | 2.00 | 2.00 | 0.00 |
Diluted Normalized EPS | 13.26 | 21.57 | 44.62 | 23.59 |
Tatva Chintan Pharma Chem Dividend Tatva Chintan Pharma Chem Bonus Tatva Chintan Pharma Chem News Tatva Chintan Pharma Chem AGM Tatva Chintan Pharma Chem Rights Tatva Chintan Pharma Chem Splits Tatva Chintan Pharma Chem Board Meetings Tatva Chintan Pharma Chem Key Metrics Tatva Chintan Pharma Chem Shareholdings Tatva Chintan Pharma Chem Balance Sheet Tatva Chintan Pharma Chem Cashflow Tatva Chintan Pharma Chem Q1 Results Tatva Chintan Pharma Chem Q2 Results Tatva Chintan Pharma Chem Q3 Results Tatva Chintan Pharma Chem Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks